Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108470
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108470
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108470
Figure 1 Study flowchart.
CRC: Colorectal cancer; AJCC: American Joint Committee on Cancer; SEER: Surveillance, Epidemiology, and End Results; LNs: Lymph nodes; ACT: Adjuvant chemotherapy.
Figure 2 Kaplan-Meier analysis of overall survival in stage II colon cancer patients with examined lymph nodes ≥ 12.
A: The Surveillance, Epidemiology, and End Results cohort before propensity score matching (PSM); B: The Surveillance, Epidemiology, and End Results cohort after PSM; C: The Chinese cohort before PSM; D: The Chinese cohort after PSM.
Figure 3 Kaplan-Meier analysis of overall survival in stage II colon cancer patients with examined lymph nodes ≥ 12, grade 1/2, and T3.
A: The Surveillance, Epidemiology, and End Results cohort before propensity score matching (PSM); B: The Surveillance, Epidemiology, and End Results cohort after PSM; C: The Chinese cohort before PSM; D: The Chinese cohort after PSM.
- Citation: Huo Y, Zhang YY, Jiao S, Bai ZY, Bai WQ, Zhou HT, Guan X. Efficacy of adjuvant chemotherapy in stage II colon cancer patients with twelve or more lymph nodes retrieve. World J Gastrointest Oncol 2025; 17(9): 108470
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/108470.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.108470